Results about: Friedreich's ataxia

New research front to tackle Friedreich’s Ataxia

IRB Barcelona starts a project with the long-term goal to achieve an injectable frataxin treatment able to reach the brain.

Frataxin is the protein that is reduced in those affected by this rare and degenerative disease, which has no cure.

The patients’ associations Babel Family and ASOGAF in Granada provide the funding for the initial 18 months of this challenge.

From chemical design to synthetic biology: two complementary strategies to tackle the BBB

Back from a very rewarding stay in Yale, Pol already has new ideas in mind to overcome the barrier that protects the brain and makes it so difficult to design drugs to cure neurological diseases.

Ambulances for the brain supported by the RecerCaixa Programme

Gate2Brain is one of the projects to receive research funding from the Obra Social “la Caixa”

The results of the IRB Barcelona project could have applications in various neurodegenerative diseases

Of the 221 projects presented, only 26 have been awarded funding